SLU-PP-332 is a synthetic research compound investigated in laboratory settings for its selective modulation of estrogen receptors. Laboratory research involving SLU-PP-332 explores its potential roles in estrogen receptor signaling, cellular proliferation, and hormonal modulation. Studies indicate SLU-PP-332 may provide insights into estrogenic pathways and receptor-specific responses.
Scientific investigations continue to explore SLU-PP-332’s potential impacts on cellular growth, hormone receptor interactions, and signaling pathways in controlled laboratory environments.
Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of SLU-PP-332 outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).
Product Specifications:
- Formulation: Tablet, 250mcg or 20mg per tablet
- Molecular Formula: C18H14N2O2
- Molecular Weight: 290.3 g/mol
- CAS Number: 303760-60-3

Source: PubChem